| Sotorasib for Lung Cancers with KRAS p.G12C Mutation F Skoulidis, BT Li, GK Dy, TJ Price, GS Falchook, J Wolf, A Italiano, ... New England Journal of Medicine 384 (25), 2371-2381, 2021 | 1178 | 2021 |
| Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry J Mazieres, A Drilon, A Lusque, L Mhanna, AB Cortot, L Mezquita, ... Annals of Oncology 30 (8), 1321-1328, 2019 | 1061 | 2019 |
| Germinal centers determine the prognostic relevance of tertiary lymphoid structures and are impaired by corticosteroids in lung squamous cell carcinoma K Siliņa, A Soltermann, FM Attar, R Casanova, ZM Uckeley, H Thut, ... Cancer research 78 (5), 1308-1320, 2018 | 278 | 2018 |
| Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial R Rosell, U Dafni, E Felip, A Curioni-Fontecedro, O Gautschi, S Peters, ... The Lancet Respiratory Medicine 5 (5), 435-444, 2017 | 216 | 2017 |
| Targeted therapy for patients with BRAF-mutant lung cancer results from the European EURAF cohort O Gautschi, J Milia, B Cabarrou, MV Bluthgen, B Besse, EF Smit, J Wolf, ... Journal of Thoracic Oncology 10 (10), 1451-1457, 2015 | 204 | 2015 |
| A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic … S Popat, A Curioni-Fontecedro, U Dafni, R Shah, M O'Brien, A Pope, ... Annals of Oncology 31 (12), 1734-1745, 2020 | 183 | 2020 |
| Frequent PD-L1 expression in testicular germ cell tumors CD Fankhauser, A Curioni-Fontecedro, V Allmann, J Beyer, V Tischler, ... British journal of cancer 113 (3), 411-413, 2015 | 167 | 2015 |
| Particle size and activation threshold: a new dimension of danger signaling L Rettig, SP Haen, AG Bittermann, L von Boehmer, A Curioni, SD Krämer, ... Blood, The Journal of the American Society of Hematology 115 (22), 4533-4541, 2010 | 138 | 2010 |
| Automated detection of lung cancer at ultralow dose PET/CT by deep neural networks–initial results M Schwyzer, DA Ferraro, UJ Muehlematter, A Curioni-Fontecedro, ... Lung Cancer 126, 170-173, 2018 | 120 | 2018 |
| How we treat patients with lung cancer during the SARS-CoV-2 pandemic: primum non nocere G Banna, A Curioni-Fontecedro, A Friedlaender, A Addeo ESMO open 4, e000765, 2019 | 115 | 2019 |
| Activity of afatinib in heavily pretreated patients with ERBB2 mutation–positive advanced NSCLC: findings from a global named patient use program S Peters, A Curioni-Fontecedro, H Nechushtan, JY Shih, WY Liao, ... Journal of Thoracic Oncology 13 (12), 1897-1905, 2018 | 78 | 2018 |
| Evaluation of NGS and RT-PCR methods for ALK rearrangement in European NSCLC patients: results from the European Thoracic Oncology Platform Lungscape Project I Letovanec, S Finn, P Zygoura, P Smyth, A Soltermann, L Bubendorf, ... Journal of Thoracic Oncology 13 (3), 413-425, 2018 | 77 | 2018 |
| IgE‐mediated allergy to corn: a 50 kDa protein, belonging to the Reduced Soluble Proteins, is a major allergen G Pasini, B Simonato, A Curioni, S Vincenzi, A Cristaudo, B Santucci, ... Allergy 57 (2), 98-106, 2002 | 77 | 2002 |
| Mutant HRAS as novel target for MEK and mTOR inhibitors MK Kiessling, A Curioni-Fontecedro, P Samaras, K Atrott, J Cosin-Roger, ... Oncotarget 6 (39), 42183, 2015 | 66 | 2015 |
| MAGE‐C1/CT‐7 expression in plasma cell myeloma: sub‐cellular localization impacts on clinical outcome M Tinguely, B Jenni, A Knights, B Lopes, D Korol, V Rousson, ... Cancer science 99 (4), 720-725, 2008 | 66 | 2008 |
| A multicentre randomized phase III trial comparing pembrolizumab (P) vs single agent chemotherapy (CT) for advanced pre-treated malignant pleural mesothelioma (MPM): results … S Popat, A Curioni-Fontecedro, V Polydoropoulou, R Shah, M O’Brien, ... Annals of Oncology 30, v931, 2019 | 63 | 2019 |
| Expression of MAGE-C1/CT7 and MAGE-C2/CT10 predicts lymph node metastasis in melanoma patients A Curioni-Fontecedro, N Nuber, D Mihic-Probst, B Seifert, D Soldini, ... PloS one 6 (6), e21418, 2011 | 63 | 2011 |
| 18F-FDG PET/CT of Non–Small Cell Lung Carcinoma Under Neoadjuvant Chemotherapy: Background-Based Adaptive-Volume Metrics Outperform TLG and MTV in Predicting Histopathologic … IA Burger, R Casanova, S Steiger, L Husmann, P Stolzmann, ... Journal of Nuclear Medicine 57 (6), 849-854, 2016 | 60 | 2016 |
| Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy–results from the randomised phase II ETOP/IFCT 4-12 … S Peters, JL Pujol, U Dafni, M Dómine, S Popat, M Reck, J Andrade, ... Annals of Oncology 33 (1), 67-79, 2022 | 59 | 2022 |
| A new era of oncology through artificial intelligence A Curioni-Fontecedro ESMO open 2 (2), 2017 | 57 | 2017 |
